SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 105 filers reported holding SCHOLAR ROCK HLDG CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $152,664 | +46.2% | 21,502 | +55.3% | 0.00% | – |
Q2 2023 | $104,406 | +703.1% | 13,847 | +471.7% | 0.00% | – |
Q2 2022 | $13,000 | -94.7% | 2,422 | -87.2% | 0.00% | – |
Q1 2022 | $243,000 | -49.2% | 18,886 | -2.0% | 0.00% | – |
Q4 2021 | $478,000 | -22.9% | 19,272 | +2.7% | 0.00% | – |
Q3 2021 | $620,000 | +11.3% | 18,767 | -2.7% | 0.00% | – |
Q2 2021 | $557,000 | -80.8% | 19,282 | -66.4% | 0.00% | -100.0% |
Q1 2021 | $2,908,000 | -65.6% | 57,406 | -67.0% | 0.00% | -60.0% |
Q4 2020 | $8,442,000 | +3668.8% | 173,946 | +1273.7% | 0.01% | – |
Q3 2020 | $224,000 | +6.7% | 12,663 | +9.5% | 0.00% | – |
Q2 2020 | $210,000 | +176.3% | 11,569 | +85.7% | 0.00% | – |
Q1 2020 | $76,000 | -9.5% | 6,231 | -3.4% | 0.00% | – |
Q4 2019 | $84,000 | +95.3% | 6,451 | +29.2% | 0.00% | – |
Q3 2019 | $43,000 | -77.5% | 4,994 | -58.7% | 0.00% | – |
Q2 2019 | $191,000 | -45.9% | 12,096 | -36.1% | 0.00% | – |
Q1 2019 | $353,000 | +90.8% | 18,915 | +132.9% | 0.00% | – |
Q4 2018 | $185,000 | -72.9% | 8,120 | -69.4% | 0.00% | – |
Q3 2018 | $682,000 | – | 26,549 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
Atom Investors LP | 25,839 | $333,000 | 0.16% |
GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |